ICON Public Limited Company EV/EBITDA Ratio 2011-2026 | ICLR

Annual EV/EBITDA Ratio ICON Public Limited Company

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
38	22.3	18.3	17.2	15.3	12.8	12.5	13.5	14.6	14.8	15.3

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
38	12.5	17.7

EV/EBITDA Ratio of other stocks in the Diagnostics research industry

Issuer	EV/EBITDA Ratio	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	0.387	-	-6.23 %	$ 30.6 M	Germany
Burning Rock Biotech Limited BNR	-1.51	$ 15.85	-2.49 %	$ 171 M	China
Agilent Technologies A	27.4	$ 115.06	-0.29 %	$ 35 B	USA
Aspira Women's Health AWH	-2.63	-	-6.19 %	$ 10.5 M	USA
Biocept BIOC	-26.9	-	-13.05 %	$ 7.29 M	USA
BioNano Genomics BNGO	-7.71	$ 1.13	-2.59 %	$ 6.15 M	USA
Chembio Diagnostics CEMI	-1.23	-	0.22 %	$ 16.8 M	USA
Check-Cap Ltd. CHEK	-0.674	-	-	$ 9.42 M	Israel
DermTech DMTK	-2.44	-	-11.32 %	$ 2.94 M	USA
CareDx, Inc CDNA	-100	$ 16.05	-3.83 %	$ 855 M	USA
Oxford Immunotec Global PLC OXFD	-73.4	-	-	$ 562 M	Britain
Akumin AKU	28.1	-	-17.87 %	$ 25.9 M	Canada
Enzo Biochem ENZ	58.3	-	-8.98 %	$ 14.8 K	USA
Co-Diagnostics CODX	3.62	$ 4.4	101.83 %	$ 5.85 M	USA
Exact Sciences Corporation EXAS	-20.8	-	-	$ 19.8 B	USA
Accelerate Diagnostics AXDX	-5.56	-	-61.36 %	$ 2.46 M	USA
Castle Biosciences CSTL	-21.2	$ 23.13	-1.28 %	$ 642 M	USA
Global Cord Blood Corporation CO	-3.52	-	-	$ 399 M	China
Fluidigm Corporation FLDM	-13.6	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	-2.67	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	-2.67	-	0.12 %	$ 80.1 M	China
Interpace Biosciences IDXG	-6.02	$ 2.3	-	$ 10.2 M	USA
Charles River Laboratories International CRL	22	$ 175.65	0.06 %	$ 8.71 B	USA
PRA Health Sciences, Inc. PRAH	20.8	-	-	$ 10.7 B	USA
Danaher Corporation DHR	20.1	$ 189.61	-1.7 %	$ 135 B	USA
Heska Corporation HSKA	141	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	-1.42	-	-20.0 %	$ 1.06 M	USA
Medpace Holdings MEDP	30.7	$ 493.53	-1.59 %	$ 14.2 B	USA
Illumina ILMN	70.5	$ 120.93	-2.22 %	$ 19.2 B	USA
Fulgent Genetics FLGT	2.58	$ 14.43	-3.93 %	$ 436 M	USA
Myriad Genetics MYGN	-17.2	$ 4.35	-2.03 %	$ 403 M	USA
NeoGenomics NEO	-33.5	$ 7.69	-3.17 %	$ 985 M	USA
Guardant Health GH	-28.8	$ 78.6	-9.83 %	$ 9.85 B	USA
QIAGEN N.V. QGEN	13.2	-	-	$ 10.6 B	Niderland
Anixa Biosciences ANIX	-2.25	$ 2.69	-1.82 %	$ 87.3 K	USA
Biomerica BMRA	-6.24	$ 2.13	-0.9 %	$ 4.89 M	USA
Invitae Corporation NVTA	-10.7	-	-	$ 21.2 M	USA
Koninklijke Philips N.V. PHG	55.6	$ 28.31	0.62 %	$ 20 B	Niderland
Laboratory Corporation of America Holdings LH	8.7	$ 260.93	-4.51 %	$ 21.7 B	USA
Natera NTRA	-19.5	$ 193.03	-4.91 %	$ 19 B	USA
Celcuity CELC	-2.38	$ 117.14	-6.02 %	$ 5.48 B	USA
Lantheus Holdings LNTH	-187	$ 80.59	-1.03 %	$ 5.44 B	USA
Motus GI Holdings MOTS	0.351	-	-34.28 %	$ 263 K	Israel
Quest Diagnostics Incorporated DGX	5.51	$ 191.51	-3.19 %	$ 21.3 B	USA
Neogen Corporation NEOG	40.3	$ 9.42	-6.13 %	$ 2.04 B	USA
ENDRA Life Sciences NDRA	0.831	$ 4.94	-6.97 %	$ 3.89 M	USA
Organovo Holdings ONVO	0.992	-	-2.3 %	$ 19.4 M	USA
OpGen OPGN	0.274	-	-16.95 %	$ 1.54 M	USA
National Research Corporation NRC	21	$ 16.48	-3.34 %	$ 369 M	USA